Boston Scientific Just Slashed Guidance and Wall Street Followed. Is the Pullback a Buying Opportunity?

1 hour ago 2

David Moadel

Thu, April 23, 2026 astatine 12:11 PM CDT 4 min read

Boston Scientific (BSX) chopped its full-year integrated maturation guidance to 6.5%-8% owed to softness successful WATCHMAN, U.S. electrophysiology, and Urology, but each 3 large expert firms (Wells Fargo, Barclays, Needham) maintained bullish ratings portion lowering terms targets to $75-$96, viewing the pullback arsenic a reset opportunity.
Management acknowledged weakness successful cardinal franchises and macro headwinds, but the cardiovascular conception delivered $3.503B successful Q1 gross (up 13.5%) with affirmative proceedings readouts successful CHAMPION-AF and FARAPULSE, positioning Boston Scientific for betterment erstwhile guidance expectations reset.
The expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks. Get them present FREE.

Boston Scientific (NYSE:BSX) banal has taken a beating successful 2026 aft absorption chopped full-year guidance connected Wednesday. On Thursday, 3 large firms trimmed terms targets portion keeping bullish ratings intact. The setup looks similar a classical reset-the-bar, then-outperform script for diligent investors.

Wells Fargo lowered its terms people connected Boston Scientific banal to $75 from $94, Barclays chopped to $96 from $100, and Needham moved to $77 from $97. All 3 firms maintained Overweight oregon Buy ratings. The connection from Wall Street: the semipermanent maturation communicative remains intact, simply recalibrated.

Ticker

Company

Firm

Action

Old Rating

New Rating

Old Target

New Target

BSX	Boston Scientific	Wells Fargo	Price people cut	Overweight	Overweight	$94	$75
BSX	Boston Scientific	Barclays	Price people cut	Overweight	Overweight	$100	$96
BSX	Boston Scientific	Needham	Price people cut	Buy	Buy	$97	$77

Wells Fargo said the revised forecast for Boston Scientific banal appears much realistic, acknowledging management's right-sizing aft weakness successful WATCHMAN, U.S. electrophysiology, and Urology. Barclays argued that with expectations reset, charismatic extremity markets, and buybacks coming, BSX volition "significantly outperform" implicit the adjacent year.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks. Get them present FREE.

Needham kept its Buy standing connected BSX banal portion acknowledging near-term choppiness. The communal thread: the cardinal franchise is intact, and the guidance chopped de-risks the narrative. For discourse connected the broader medtech reset, spot our caller sum of healthcare valuations.

Boston Scientific is simply a planetary aesculapian instrumentality shaper with starring franchises successful cardiovascular, endoscopy, urology, and neuromodulation. Q1 gross came successful astatine $5.203 billion, up 11.6% twelvemonth implicit year, with integrated maturation of 9.4% and adjusted EPS of 80 cents, extending a four-quarter bushed streak.

Read Entire Article